Ammar Abdulrahman Jairoun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ammar Abdulrahman Jairoun has a total of 364 co-authors. Here are the top co-authors by number of shared publications:
- Moyad Shahwan
Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates
80 shared publications - Sabaa Saleh Al-Hemyari
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Pulau Pinang, Malaysia
36 shared publications Sabaa Saleh Al-Hemyari
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Pulau Pinang, Malaysia
31 shared publications- Faris El-Dahiyat
Clinical Pharmacy Program, Al Ain University , Al Ain
25 shared publications Moyad Shahwan
Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates
24 shared publications- Sa’eD H. Zyoud
An-Najah National University
24 shared publications
Latest Publications
- 6 November 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (12)
Development and validation of the Arabic international index of erectile Function-5 (IIEF-5): a population-based assessment of erectile dysfunction severity and its associated factors among Arabic-speaking older men
Introduction: Although an Arabic version of the International Index of Erectile Function-5 (IIEF-5) has previously been validated, further evidence regarding its structural validity and reliability among older Arabic-speaking men from different countries is needed. This study evaluated the psychometric properties of an Arabic IIEF-5 among older men and examined sociodemographic and health-related factors associated with erectile dysfunction severity. Methods: A cross-sectional study was conducted among 522 Arabic-speaking men aged ≥60 years from several Arab countries. Content validity was evaluated by an expert panel. Structural validity was examined using confirmatory factor analysis with robust maximum likelihood estimation. Internal consistency, composite reliability, convergent validity, and test–retest reliability were assessed. Ordinal logistic regression identified independent predictors of ED severity. Results: The Arabic IIEF-5 demonstrated a unidimensional structure with good model fit under robust estimation (Satorra–Bentler χ2 (4) = 7.30, p = 0.121; CFI = 0.992; NNFI = 0.981; RMSEA = 0.040; SRMR = 0.022). Standardized factor loadings ranged from 0.560 to 0.749. Internal consistency was good (Cronbach’s α = 0.811), with composite reliability of 0.819, rho of 0.832, and acceptable convergent validity (AVE = 0.477). Test–retest reliability confirmed score stability. Ordinal logistic regression showed that smoking (OR = 1.65, 95% CI: 1.12-2.45), irregular physical activity (OR = 5.08, 95% CI: 3.39-7.59), no physical activity (OR = 8.54, 95% CI: 4.28-17.04), chronic disease (OR = 7.48, 95% CI: 4.63-12.08), and postgraduate education (OR = 2.14, 95% CI: 1.15-3.97) were independently associated with greater ED severity. Discussions: The Arabic IIEF-5 is a reliable and valid instrument for assessing erectile function in Arabic-speaking older men. Future research should employ longitudinal designs, include participants from multiple Arab countries, and incorporate comprehensive clinical assessments, including physician-confirmed diagnoses and objective clinical measures, to further strengthen criterion validity and evaluate measurement invariance across diverse Arabic-speaking populations.
- 6 November 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (12)
Development and validation of the Arabic international index of erectile Function-5 (IIEF-5): a population-based assessment of erectile dysfunction severity and its associated factors among Arabic-speaking older men
Introduction: Although an Arabic version of the International Index of Erectile Function-5 (IIEF-5) has previously been validated, further evidence regarding its structural validity and reliability among older Arabic-speaking men from different countries is needed. This study evaluated the psychometric properties of an Arabic IIEF-5 among older men and examined sociodemographic and health-related factors associated with erectile dysfunction severity. Methods: A cross-sectional study was conducted among 522 Arabic-speaking men aged ≥60 years from several Arab countries. Content validity was evaluated by an expert panel. Structural validity was examined using confirmatory factor analysis with robust maximum likelihood estimation. Internal consistency, composite reliability, convergent validity, and test–retest reliability were assessed. Ordinal logistic regression identified independent predictors of ED severity. Results: The Arabic IIEF-5 demonstrated a unidimensional structure with good model fit under robust estimation (Satorra–Bentler χ2 (4) = 7.30, p = 0.121; CFI = 0.992; NNFI = 0.981; RMSEA = 0.040; SRMR = 0.022). Standardized factor loadings ranged from 0.560 to 0.749. Internal consistency was good (Cronbach’s α = 0.811), with composite reliability of 0.819, rho of 0.832, and acceptable convergent validity (AVE = 0.477). Test–retest reliability confirmed score stability. Ordinal logistic regression showed that smoking (OR = 1.65, 95% CI: 1.12-2.45), irregular physical activity (OR = 5.08, 95% CI: 3.39-7.59), no physical activity (OR = 8.54, 95% CI: 4.28-17.04), chronic disease (OR = 7.48, 95% CI: 4.63-12.08), and postgraduate education (OR = 2.14, 95% CI: 1.15-3.97) were independently associated with greater ED severity. Discussions: The Arabic IIEF-5 is a reliable and valid instrument for assessing erectile function in Arabic-speaking older men. Future research should employ longitudinal designs, include participants from multiple Arab countries, and incorporate comprehensive clinical assessments, including physician-confirmed diagnoses and objective clinical measures, to further strengthen criterion validity and evaluate measurement invariance across diverse Arabic-speaking populations.
- 22 October 2026
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (6) , 129
Readiness for precision medicine: pharmacogenomic literacy among adults surveyed in the United Arab Emirates: a cross-sectional study
Background Pharmacogenomics is increasingly being incorporated into precision medicine to support safer and more effective drug therapy. As the clinical use of pharmacogenomic testing expands, public understanding of its purpose and limitations becomes increasingly important. However, information on pharmacogenomic literacy among the general population in the United Arab Emirates (UAE) is scarce. Objective This study aimed to assess pharmacogenomic literacy among adults in the UAE using the Minnesota Assessment of Pharmacogenomic Literacy (MAPL) and to examine sociodemographic and clinical factors associated with pharmacogenomic literacy. Methods A cross-sectional online survey was conducted between March and May 2026 among adults living in the UAE. Pharmacogenomic literacy was measured using the validated 15-item MAPL. Scores were classified as low, moderate, or high according to Bloom’s cut-off criteria. Descriptive statistics summarized participant characteristics and MAPL responses. Ordinal logistic regression was used to identify factors associated with pharmacogenomic literacy. Associations were reported as odds ratios (ORs) with 95% confidence intervals (CIs). Results A total of 626 individuals participated. The mean MAPL score was 8.1 (95% CI 7.9–8.2). Overall, 59.4% of participants had low pharmacogenomic literacy, 36.6% had moderate literacy, and 4.0% had high literacy. Participants generally showed good knowledge of basic genetic concepts, but important misconceptions were identified regarding the clinical role of pharmacogenomic testing. More than 60% incorrectly believed that pharmacogenomic testing could identify the best medication, predict responses to all medicines, or establish a medical diagnosis. Previous experience with genetic testing was associated with higher pharmacogenomic literacy (OR = 2.43, 95% CI 2.09–2.83; p < 0.001). Participants aged 35–44 years had slightly lower odds of higher literacy than those aged 45 years or older (OR = 0.91, 95% CI 0.82-1.00; p < 0.05). No significant associations were observed for sex and employment status. Conclusions Pharmacogenomic literacy among adults in the UAE was limited despite a reasonable understanding of basic genetic principles. The largest knowledge gaps concerned the clinical applications and limitations of pharmacogenomic testing. Previous genetic testing experience was associated with better literacy. These findings support accessible educational initiatives and patient-centered communication to promote informed use of pharmacogenomics as precision medicine becomes more widely implemented.
- 22 October 2026
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (6) , 129
Readiness for precision medicine: pharmacogenomic literacy among adults surveyed in the United Arab Emirates: a cross-sectional study
Background Pharmacogenomics is increasingly being incorporated into precision medicine to support safer and more effective drug therapy. As the clinical use of pharmacogenomic testing expands, public understanding of its purpose and limitations becomes increasingly important. However, information on pharmacogenomic literacy among the general population in the United Arab Emirates (UAE) is scarce. Objective This study aimed to assess pharmacogenomic literacy among adults in the UAE using the Minnesota Assessment of Pharmacogenomic Literacy (MAPL) and to examine sociodemographic and clinical factors associated with pharmacogenomic literacy. Methods A cross-sectional online survey was conducted between March and May 2026 among adults living in the UAE. Pharmacogenomic literacy was measured using the validated 15-item MAPL. Scores were classified as low, moderate, or high according to Bloom’s cut-off criteria. Descriptive statistics summarized participant characteristics and MAPL responses. Ordinal logistic regression was used to identify factors associated with pharmacogenomic literacy. Associations were reported as odds ratios (ORs) with 95% confidence intervals (CIs). Results A total of 626 individuals participated. The mean MAPL score was 8.1 (95% CI 7.9–8.2). Overall, 59.4% of participants had low pharmacogenomic literacy, 36.6% had moderate literacy, and 4.0% had high literacy. Participants generally showed good knowledge of basic genetic concepts, but important misconceptions were identified regarding the clinical role of pharmacogenomic testing. More than 60% incorrectly believed that pharmacogenomic testing could identify the best medication, predict responses to all medicines, or establish a medical diagnosis. Previous experience with genetic testing was associated with higher pharmacogenomic literacy (OR = 2.43, 95% CI 2.09–2.83; p < 0.001). Participants aged 35–44 years had slightly lower odds of higher literacy than those aged 45 years or older (OR = 0.91, 95% CI 0.82-1.00; p < 0.05). No significant associations were observed for sex and employment status. Conclusions Pharmacogenomic literacy among adults in the UAE was limited despite a reasonable understanding of basic genetic principles. The largest knowledge gaps concerned the clinical applications and limitations of pharmacogenomic testing. Previous genetic testing experience was associated with better literacy. These findings support accessible educational initiatives and patient-centered communication to promote informed use of pharmacogenomics as precision medicine becomes more widely implemented.
- Open Access
- 18 September 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Determinants of community pharmacists’ intention to provide pharmacist-driven vaccination services in selected Arabic-speaking countries: a theory of planned behaviour-based structural equation modelling study
1. Community pharmacists have become increasingly recognised as accessible healthcare professionals who contribute substantially to disease prevention and health promotion through the delivery of v...
- 18 September 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Open AccessDeterminants of community pharmacists’ intention to provide pharmacist-driven vaccination services in selected Arabic-speaking countries: a theory of planned behaviour-based structural equation modelling study
1. Community pharmacists have become increasingly recognised as accessible healthcare professionals who contribute substantially to disease prevention and health promotion through the delivery of v...
- Open Access
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50118
Global trends in e-cigarette regulatory compliance
Background: Electronic cigarettes, commonly referred to as e-cigarettes, have spread rapidly across global markets. Their growth has created regulatory concerns involving product safety, nicotine levels, youth access, advertising practices, flavor controls, and protection of public health. Countries have adopted different regulatory approaches because of variation in public health priorities, tobacco-control policies, and legal systems. Bibliometric analysis cannot measure whether regulations are effective, but it can show how the scientific literature informing policy has developed and where new regulatory concerns are emerging. Objective: This study aimed to map the global scientific literature on e-cigarette regulation and regulatory compliance, identify major contributors and research patterns, and detect emerging policy-related topics that require further study. Methods: A bibliometric analysis was conducted using Scopus-indexed publications published between 2004 and August 2024. After applying predefined eligibility criteria, the final records were analyzed using VOSviewer software (Centre for Science and Technology Studies, Leiden University). The analysis examined publication growth, citation activity, co-authorship networks, institutional and country collaborations, co-citation links, keyword co-occurrence, and overlay visualization. Results: The final dataset included 984 publications. The United States, the United Kingdom, and Canada were the most active countries in this research area. The University of Waterloo, King’s College London, and the Ontario Institute for Cancer Research were among the leading institutions. The main journals publishing work in this field were Nicotine & Tobacco Research, Tobacco Control, and the International Journal of Environmental Research and Public Health. Keyword findings showed a gradual movement away from broader tobacco-control research toward topics such as youth vaping, electronic nicotine delivery systems, flavor regulation, public policy, and regulatory compliance. These patterns reflect changing research priorities that can support future regulatory studies and policy development. Conclusion: Scientific research on e-cigarette regulation has grown markedly during the past 2 decades. Although bibliometric methods cannot determine whether a policy works, they provide a structured view of how evidence in this field has developed. Future studies should combine bibliometric findings with comparative policy studies to improve understanding of how e-cigarette regulatory frameworks are implemented and what effects they produce.
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50118
Open AccessGlobal trends in e-cigarette regulatory compliance
Background: Electronic cigarettes, commonly referred to as e-cigarettes, have spread rapidly across global markets. Their growth has created regulatory concerns involving product safety, nicotine levels, youth access, advertising practices, flavor controls, and protection of public health. Countries have adopted different regulatory approaches because of variation in public health priorities, tobacco-control policies, and legal systems. Bibliometric analysis cannot measure whether regulations are effective, but it can show how the scientific literature informing policy has developed and where new regulatory concerns are emerging. Objective: This study aimed to map the global scientific literature on e-cigarette regulation and regulatory compliance, identify major contributors and research patterns, and detect emerging policy-related topics that require further study. Methods: A bibliometric analysis was conducted using Scopus-indexed publications published between 2004 and August 2024. After applying predefined eligibility criteria, the final records were analyzed using VOSviewer software (Centre for Science and Technology Studies, Leiden University). The analysis examined publication growth, citation activity, co-authorship networks, institutional and country collaborations, co-citation links, keyword co-occurrence, and overlay visualization. Results: The final dataset included 984 publications. The United States, the United Kingdom, and Canada were the most active countries in this research area. The University of Waterloo, King’s College London, and the Ontario Institute for Cancer Research were among the leading institutions. The main journals publishing work in this field were Nicotine & Tobacco Research, Tobacco Control, and the International Journal of Environmental Research and Public Health. Keyword findings showed a gradual movement away from broader tobacco-control research toward topics such as youth vaping, electronic nicotine delivery systems, flavor regulation, public policy, and regulatory compliance. These patterns reflect changing research priorities that can support future regulatory studies and policy development. Conclusion: Scientific research on e-cigarette regulation has grown markedly during the past 2 decades. Although bibliometric methods cannot determine whether a policy works, they provide a structured view of how evidence in this field has developed. Future studies should combine bibliometric findings with comparative policy studies to improve understanding of how e-cigarette regulatory frameworks are implemented and what effects they produce.
- Open Access
- 5 August 2026
- Published by Frontiers Media SA in Frontiers in Education
- Vol. 11, 1899754
Translation, cultural adaptation, and psychometric validation of the WHO-5 well-being index for Arabic-speaking university students
Introduction: University life is a formative period characterized by increased autonomy, evolving social roles, and sustained academic demands, placing students at heightened risk of psychological distress. Reliable assessment of subjective well-being is essential for early identification, prevention, and the promotion of adaptive functioning. This study aimed to translate, culturally adapt, and evaluate the psychometric properties of the Arabic version of the World Health Organization-Five Well-Being Index (WHO-5) among university students in the United Arab Emirates (UAE). Methods: A cross-sectional psychometric validation study was conducted between February 2024 and March 2025 using an online survey of 568 university students in the UAE. The translation and cultural adaptation followed a standardized seven-step process, including forward translation, reconciliation, backward translation, comparison with the original instrument, pilot testing, and psychometric evaluation. Construct validity was assessed using confirmatory factor analysis with robust maximum likelihood estimation. Model fit was evaluated using McDonald's fit index (MFI), comparative fit index (CFI), incremental fit index (IFI), normed fit index (NFI), non-normed fit index (NNFI), and root mean square error of approximation (RMSEA). Convergent validity, internal consistency reliability, and measurement invariance across gender were also examined. Results: The original one-factor model demonstrated suboptimal fit. After specifying two theoretically justifiable residual correlations between WHO_1 and WHO_4 and between WHO_2 and WHO_5, the modified one-factor model showed good fit under the robust solution (CFI = 0.993, NFI = 0.990, NNFI = 0.976, RMSEA = 0.068; 90% CI: 0.027 -0.113). Standardized factor loadings ranged from 0.508 to 0.805. Convergent validity was supported by an average variance extracted of 0.533, while internal consistency was demonstrated by a Cronbach's α of 0.833 and composite reliability of 0.848. Multi-group confirmatory factor analysis provided preliminary evidence of configural, metric, and scalar invariance across gender. However, the elevated absolute RMSEA values observed in the gender-specific and multi-group models indicate that these invariance findings should be interpreted with caution. Discussion: The Arabic WHO-5 demonstrated satisfactory preliminary evidence of construct validity, convergent validity, internal consistency, and measurement invariance among university students in the UAE. These findings support its use as a brief measure of subjective well-being in this population. Nevertheless, the results represent an initial validation rather than definitive evidence for widespread research or clinical application. Future multicenter and longitudinal studies should evaluate test -retest reliability, relationships with established mental health measures, diagnostic performance, clinical utility, and measurement invariance across broader Arabic-speaking populations.
- 5 August 2026
- Published by Frontiers Media SA in Frontiers in Education
- Vol. 11, 1899754
Open AccessTranslation, cultural adaptation, and psychometric validation of the WHO-5 well-being index for Arabic-speaking university students
Introduction: University life is a formative period characterized by increased autonomy, evolving social roles, and sustained academic demands, placing students at heightened risk of psychological distress. Reliable assessment of subjective well-being is essential for early identification, prevention, and the promotion of adaptive functioning. This study aimed to translate, culturally adapt, and evaluate the psychometric properties of the Arabic version of the World Health Organization-Five Well-Being Index (WHO-5) among university students in the United Arab Emirates (UAE). Methods: A cross-sectional psychometric validation study was conducted between February 2024 and March 2025 using an online survey of 568 university students in the UAE. The translation and cultural adaptation followed a standardized seven-step process, including forward translation, reconciliation, backward translation, comparison with the original instrument, pilot testing, and psychometric evaluation. Construct validity was assessed using confirmatory factor analysis with robust maximum likelihood estimation. Model fit was evaluated using McDonald's fit index (MFI), comparative fit index (CFI), incremental fit index (IFI), normed fit index (NFI), non-normed fit index (NNFI), and root mean square error of approximation (RMSEA). Convergent validity, internal consistency reliability, and measurement invariance across gender were also examined. Results: The original one-factor model demonstrated suboptimal fit. After specifying two theoretically justifiable residual correlations between WHO_1 and WHO_4 and between WHO_2 and WHO_5, the modified one-factor model showed good fit under the robust solution (CFI = 0.993, NFI = 0.990, NNFI = 0.976, RMSEA = 0.068; 90% CI: 0.027 -0.113). Standardized factor loadings ranged from 0.508 to 0.805. Convergent validity was supported by an average variance extracted of 0.533, while internal consistency was demonstrated by a Cronbach's α of 0.833 and composite reliability of 0.848. Multi-group confirmatory factor analysis provided preliminary evidence of configural, metric, and scalar invariance across gender. However, the elevated absolute RMSEA values observed in the gender-specific and multi-group models indicate that these invariance findings should be interpreted with caution. Discussion: The Arabic WHO-5 demonstrated satisfactory preliminary evidence of construct validity, convergent validity, internal consistency, and measurement invariance among university students in the UAE. These findings support its use as a brief measure of subjective well-being in this population. Nevertheless, the results represent an initial validation rather than definitive evidence for widespread research or clinical application. Future multicenter and longitudinal studies should evaluate test -retest reliability, relationships with established mental health measures, diagnostic performance, clinical utility, and measurement invariance across broader Arabic-speaking populations.
- Open Access
- 17 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (29) , e49734
Disclosing the diagnosis of terminal-stage cancer to patients: attitudes amongst UAE healthcare providers and universities’ students: A cross-sectional study
Disclosing a cancer diagnosis, particularly to individuals in family-centric cultures, is a complex process that directly impacts patient-centered care. This study explores the factors that influence attitudes toward truth disclosure of a terminal cancer diagnosis in the diverse population of the United Arab Emirates and compares these findings with practices in other nations and regions. A descriptive cross-sectional study was conducted using an online self-administered questionnaire. The questionnaire comprised 4 sections: 9 questions collected demographic data, 6 questions assessed respondents’ perceptions regarding the diagnosis of terminal-stage cancer, 7 questions evaluated their perceptions of its prognosis, and 7 questions focused on their views on truth disclosure in terminal-stage cancer. The questionnaire was developed based on existing literature and expert input. The study targeted healthcare providers, as well as all students (undergraduate or postgraduate), faculty members, and staff at universities in the United Arab Emirates. Multivariate logistic regression models were applied to determine the factors influencing participants’ attitudes and perceptions. A total of 495 participants were recruited, with 73.7% being female and 26.3% being male. The majority (45.9%) were aged 18 to 24 years. The average attitude scores were 87.8% for the diagnosis of terminal-stage cancer, 85.8% for its prognosis, and 69.7% for truth disclosure to family. Logistic regression analysis showed that female participants had more positive attitudes toward diagnosis (odds ratio [OR] = 1.85; 95% confidence interval [CI]: 1.1–3.1), while participants from the Middle East and North Africa had less positive attitudes toward both diagnosis (OR = 0.653; 95% CI: 0.48–0.87) and prognosis (OR = 0.652; 95% CI: 0.47–0.86). More positive attitudes toward truth disclosure were observed among participants from South Asia (OR = 1.52; 95% CI: 1.25–1.85) and Southeast Asia/Oceania (OR = 2.1; 95% CI: 1.63–2.70), as well as among nurses (OR = 5.15; 95% CI: 2.64–10.03) and Christian participants (OR = 4; 95% CI: 1.02–15.6), whereas single participants exhibited less positive attitudes (OR = 0.560; 95% CI: 0.38–0.82). These results highlight the complex interaction between cultural and demographic factors in determining perceptions of terminal-stage cancer. They emphasize the value of customized treatments and communication techniques to address different points of view, which will ultimately improve patient support and care in situations involving terminal illness.
- 17 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (29) , e49734
Open AccessDisclosing the diagnosis of terminal-stage cancer to patients: attitudes amongst UAE healthcare providers and universities’ students: A cross-sectional study
Disclosing a cancer diagnosis, particularly to individuals in family-centric cultures, is a complex process that directly impacts patient-centered care. This study explores the factors that influence attitudes toward truth disclosure of a terminal cancer diagnosis in the diverse population of the United Arab Emirates and compares these findings with practices in other nations and regions. A descriptive cross-sectional study was conducted using an online self-administered questionnaire. The questionnaire comprised 4 sections: 9 questions collected demographic data, 6 questions assessed respondents’ perceptions regarding the diagnosis of terminal-stage cancer, 7 questions evaluated their perceptions of its prognosis, and 7 questions focused on their views on truth disclosure in terminal-stage cancer. The questionnaire was developed based on existing literature and expert input. The study targeted healthcare providers, as well as all students (undergraduate or postgraduate), faculty members, and staff at universities in the United Arab Emirates. Multivariate logistic regression models were applied to determine the factors influencing participants’ attitudes and perceptions. A total of 495 participants were recruited, with 73.7% being female and 26.3% being male. The majority (45.9%) were aged 18 to 24 years. The average attitude scores were 87.8% for the diagnosis of terminal-stage cancer, 85.8% for its prognosis, and 69.7% for truth disclosure to family. Logistic regression analysis showed that female participants had more positive attitudes toward diagnosis (odds ratio [OR] = 1.85; 95% confidence interval [CI]: 1.1–3.1), while participants from the Middle East and North Africa had less positive attitudes toward both diagnosis (OR = 0.653; 95% CI: 0.48–0.87) and prognosis (OR = 0.652; 95% CI: 0.47–0.86). More positive attitudes toward truth disclosure were observed among participants from South Asia (OR = 1.52; 95% CI: 1.25–1.85) and Southeast Asia/Oceania (OR = 2.1; 95% CI: 1.63–2.70), as well as among nurses (OR = 5.15; 95% CI: 2.64–10.03) and Christian participants (OR = 4; 95% CI: 1.02–15.6), whereas single participants exhibited less positive attitudes (OR = 0.560; 95% CI: 0.38–0.82). These results highlight the complex interaction between cultural and demographic factors in determining perceptions of terminal-stage cancer. They emphasize the value of customized treatments and communication techniques to address different points of view, which will ultimately improve patient support and care in situations involving terminal illness.
- Open Access
- 23 June 2026
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 17
Precision obesity medicine: a translational perspective on epigenetics, the gut microbiome, and AI-assisted multi-omics integration
- 23 June 2026
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 17
Open AccessPrecision obesity medicine: a translational perspective on epigenetics, the gut microbiome, and AI-assisted multi-omics integration
- Open Access
- 1 March 2026
- Published by SAGE Publications in Diabetes & Vascular Disease Research
- Vol. 23 (2)
Association of vitamin D and vitamin B12 deficiencies with metabolic and hepatic parameters in patients with type 2 diabetes mellitus
Micronutrients have become one of the potentially adjustable determinants of the pathophysiology and complications of T2DM. Of them, vitamin D and B12 have been particularly highlighted. Objectives: to estimate the prevalence of both vitamin D and B12 deficiencies in parallel association with T2DM patients and their relationships with major metabolic and hepatic parameters. This study adopted a cross-sectional analytical design performed in a healthcare center located in the district of Ramallah in Palestine. In total, 295 patients fulfilled these criteria and were included in this final analysis. The present study underlines the high prevalence of vitamin D deficiency and the relatively lower, but clinically relevant, incidence of vitamin B12 deficiency in patients affected by type 2 diabetes mellitus within the adult population of the Ramallah district in Palestine. It also demonstrated that low levels of vitamin D were strongly associated with important metabolic and cardiovascular risk factors.
- 1 March 2026
- Published by SAGE Publications in Diabetes & Vascular Disease Research
- Vol. 23 (2)
Open AccessAssociation of vitamin D and vitamin B12 deficiencies with metabolic and hepatic parameters in patients with type 2 diabetes mellitus
Micronutrients have become one of the potentially adjustable determinants of the pathophysiology and complications of T2DM. Of them, vitamin D and B12 have been particularly highlighted. Objectives: to estimate the prevalence of both vitamin D and B12 deficiencies in parallel association with T2DM patients and their relationships with major metabolic and hepatic parameters. This study adopted a cross-sectional analytical design performed in a healthcare center located in the district of Ramallah in Palestine. In total, 295 patients fulfilled these criteria and were included in this final analysis. The present study underlines the high prevalence of vitamin D deficiency and the relatively lower, but clinically relevant, incidence of vitamin B12 deficiency in patients affected by type 2 diabetes mellitus within the adult population of the Ramallah district in Palestine. It also demonstrated that low levels of vitamin D were strongly associated with important metabolic and cardiovascular risk factors.
- Open Access
- 16 February 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1748459
Exploring metabolic syndrome care: insights from community pharmacists in the UAE setting-a cross-sectional questionnaire-based study
Background: Community pharmacists act as a middleman among both patients and prescribing doctors. As such, they oversee making sure that patients receive the best possible pharmaceutical care for Metabolic syndrome (MetS). There is a dearth of adequate data on MetS awareness, attitudes, and treatment practices between community pharmacists within the UAE. Objectives: To assess the attitudes of community pharmacies professionals across Abu Dhabi, Dubai, and the Northern Emirates toward managing and preventing MetS. Methods and materials: This is a cross-sectional study design carried out between May 2023 and February 2024. Four final-year pharmacy students conducted in-person interviews among professionals working in community pharmacies and structured questionnaire was utilized for information collection. The questionnaire comprised Demographic information, attitudes and practices to Prevention and Management of Metabolic Syndrome. Results: The total of 420 pharmacists were recruited for the study. The mean attitude score toward the prevention and treatment of metabolic syndrome was 75.8%, with a 95% confidence interval (CI) of [76.3, 81.4%]. The average practice score toward prevention and treatment of metabolic syndrome was 86.8% with a 95% CI of [85.3, 88.3%]. Supervising pharmacists were more likely to achieve a positive attitude score compared with assistant pharmacists (OR = 4.63; 95% CI: 2.32–9.21; p < 0.001). Pharmacists with more than 10 years of experience had higher odds of a positive attitude score compared with those with 1–5 years of practice (OR = 2.11; 95% CI: 1.11–3.99; p = 0.022). Good practice scores were significantly associated with working in chain pharmacies (OR = 1.69), holding senior professional positions (supervising pharmacist: OR = 8.39; chief pharmacist: OR = 5.90), having longer professional experience (6–10 years: OR = 5.08; >10 years: OR = 7.04), and receiving prior training on MetS (OR = 4.64; 95% CI: 2.52–8.55; p < 0.001). Conclusion: The findings show that the community pharmacists are cognizant about appropriate practices required for the treatment and management of MetS. It was inferred that the setting and quality (experience and training) of pharmacy professionals play vital roles in strengthening the attitude and practice of community pharmacists with regards to MetS.
- 16 February 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1748459
Open AccessExploring metabolic syndrome care: insights from community pharmacists in the UAE setting-a cross-sectional questionnaire-based study
Background: Community pharmacists act as a middleman among both patients and prescribing doctors. As such, they oversee making sure that patients receive the best possible pharmaceutical care for Metabolic syndrome (MetS). There is a dearth of adequate data on MetS awareness, attitudes, and treatment practices between community pharmacists within the UAE. Objectives: To assess the attitudes of community pharmacies professionals across Abu Dhabi, Dubai, and the Northern Emirates toward managing and preventing MetS. Methods and materials: This is a cross-sectional study design carried out between May 2023 and February 2024. Four final-year pharmacy students conducted in-person interviews among professionals working in community pharmacies and structured questionnaire was utilized for information collection. The questionnaire comprised Demographic information, attitudes and practices to Prevention and Management of Metabolic Syndrome. Results: The total of 420 pharmacists were recruited for the study. The mean attitude score toward the prevention and treatment of metabolic syndrome was 75.8%, with a 95% confidence interval (CI) of [76.3, 81.4%]. The average practice score toward prevention and treatment of metabolic syndrome was 86.8% with a 95% CI of [85.3, 88.3%]. Supervising pharmacists were more likely to achieve a positive attitude score compared with assistant pharmacists (OR = 4.63; 95% CI: 2.32–9.21; p < 0.001). Pharmacists with more than 10 years of experience had higher odds of a positive attitude score compared with those with 1–5 years of practice (OR = 2.11; 95% CI: 1.11–3.99; p = 0.022). Good practice scores were significantly associated with working in chain pharmacies (OR = 1.69), holding senior professional positions (supervising pharmacist: OR = 8.39; chief pharmacist: OR = 5.90), having longer professional experience (6–10 years: OR = 5.08; >10 years: OR = 7.04), and receiving prior training on MetS (OR = 4.64; 95% CI: 2.52–8.55; p < 0.001). Conclusion: The findings show that the community pharmacists are cognizant about appropriate practices required for the treatment and management of MetS. It was inferred that the setting and quality (experience and training) of pharmacy professionals play vital roles in strengthening the attitude and practice of community pharmacists with regards to MetS.